Common Contracts
2 similar Sales Agreement contracts by Allena Pharmaceuticals, Inc., Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. Shares of Common Stock ($0.00001 par value per share) SALES AGREEMENTSales Agreement • October 5th, 2021 • Taysha Gene Therapies, Inc. • Biological products, (no disgnostic substances) • New York
Taysha Gene Therapies, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC and Wells Fargo Securities, LLC (each an “Agent” and together, the “Agents”), as follows:
ALLENA PHARMACEUTICALS, INC. AT MARKET ISSUANCE SALES AGREEMENTSales Agreement • March 30th, 2021 • Allena Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
